Guidelines for management of alcoholic liver disease

Chinese Journal of Gastroenterology

Volumn 15, Issue 10, 2010, Pages 617-621

[No Author Info available]

Author keywords

Diagnosis; Fatty liver, alcoholic; Guidelines; Therapy

Indexed keywords

ALCOHOL LIVER DISEASE; CONFERENCE PAPER; PRACTICE GUIDELINE;

EID: 80054079341     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2010.10.011     Document Type: Conference Paper

References (50)

1. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology, 2004, 39 (3): 857-861. (Pubitemid 38337668)
2. Shen Z, Li YM, Yu CH, et al. Risk factors for alcohol-related liver injury in the island population of China: a population-based case-control study. World J Gastroenterol, 2008, 14 (14): 2255-2261.
3. Becker U, Deis A, Sørensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology, 1996, 23 (5): 1025-1029. (Pubitemid 26137041)
4. Kamper-Jørgensen M, Grønbaek M, Tolstrup J, et al. Alcohol and cirrhosis: dose - response or threshold effect? J Hepatol, 2004, 41 (1): 25-30.
5. Becker U, Grønbaek M, Johansen D, et al. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology, 2002, 35 (4): 868-875. (Pubitemid 34258381)
6. Lu XL, Luo JY, Tao M, et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol, 2004, 10 (16): 2423-2426. (Pubitemid 39157774)
7. Sato N, Lindros KO, Baraona E, et al. Sex difference in alcohol-related organ injury. Alcohol Clin Exp Res, 2001, 25 (5 Suppl ISBRA): 40S-45S.
8. Baraona E, Abittan CS, Dohmen K, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res, 2001, 25 (4): 502-507. (Pubitemid 32323416)
9. Wickramasinghe SN, Corridan B, Izaguirre J, et al. Ethnic differences in the biological consequences of alcohol abuse: a comparison between south Asian and European males. Alcohol Alcohol, 1995, 30 (5): 675-680.
10. Yu C, Li Y, Chen W, et al. Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people. Chin Med J (Engl), 2002, 115 (7): 1085-1087. (Pubitemid 34830791)
11. Borràs E, Coutelle C, Rosell A, et al. Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1. Hepatology, 2000, 31 (4): 984-989. (Pubitemid 30169947)
12. Mendenhall C, Roselle GA, Gartside P, et al. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res, 1995, 19 (3): 635-641.
13. Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis, 2005, 9 (1): 67-81. (Pubitemid 40341947)
14. Mezey E. Dietary fat and alcoholic liver disease. Hepatology, 1998, 28 (4): 901-905. (Pubitemid 28450247)
15. Williams R. Global challenges in liver disease. Hepatology, 2006, 44 (3): 521-526. (Pubitemid 44433707)
16. Yersin B, Nicolet JF, Dercrey H, et al. Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume. Arch Intern Med, 1995, 155 (17): 1907-1911.
17. Conigrave KM, Degenhardt LJ, Whitfield JB, et al. WHO/ISBRA Study Group. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res, 2002, 26 (3): 332-339. (Pubitemid 34225837)
18. Chen CH, Huang MH, Yang JC, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol, 2007, 22 (9): 1482-1489. (Pubitemid 47274571)
19. Majhi S, Baral N, Lamsal M, et al. De Ritis ratio as diagnostic marker of alcoholic liver disease. Nepal Med Coll J, 2006, 8 (1): 40-42.
20. Nyblom H, Berggren U, Balldin J, et al. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol, 2004, 39 (4): 336-339.
21. Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology, 2002, 123 (5): 1705-1725.
22. Graif M, Yanuka M, Baraz M, et al. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol, 2000, 35 (5): 319-324. (Pubitemid 30395315)
23. Ataseven H, Yildrim MH, Yalniz M, et al. Correlation between computerized tomographic findings and histopathologic grade/ stage in non-alcoholic steatohepatitis. J Hepatol, 2003, 38 (Suppl 2): A4177.
24. Farrell GC, George J, de la M. Hall P, et al., eds. Fatty liver disease: NASH and related disorders. Oxford: Blackwell Publishing, 2005. 159-207.
25. Srikureja W, Kyulo NL, Runyon BA, et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol, 2005, 42 (5): 700-706.
26. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol, 2004, 40 (6): 897-903. (Pubitemid 38670122)
27. Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med, 1989, 110 (9): 685-690. (Pubitemid 19121221)
28. Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol, 2007, 4 (1): 24-34. (Pubitemid 46055957)
29. Barve A, Khan R, Marsano L, et al. Treatment of alcoholic liver disease. Ann Hepatol, 2008, 7 (1): 5-15. (Pubitemid 351468533)
30. O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology, 2010, 51 (1): 307-328.
31. Stickel F, Hoehn B, Schuppan D, et al. Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther, 2003, 18 (4): 357-373. (Pubitemid 37070234)
32. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol, 2002, 36 (4): 480-487. (Pubitemid 34407335)
33. Imperiale TF, O'Connor JB, McCullough AJ. Corticosteroids are effective in patients with severe alcoholic hepatitis. Am J Gastroenterol, 1999, 94 (10): 3066-3068. (Pubitemid 29482784)
34. Shpilenya LS, Muzychenko AP, Gasbarrini G, et al. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study. Alcohol Clin Exp Res, 2002, 26 (3): 340-346. (Pubitemid 34225838)
35. Mato JM, Cámara J, Fernández de Paz J, et al. S--adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol, 1999, 30 (6): 1081-1089. (Pubitemid 29278753)
36. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs, 2005, 65 (17): 2445-2461.
37. Murray KF, Carithers RL Jr; AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology, 2005, 41 (6): 1407-1432. (Pubitemid 40770295)